'Switching Breast Cancer Drugs May Boost Survival (HealthDay)Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.